Edwards Lifesciences Long Term Debt 2012-2025 | EW
Edwards Lifesciences long term debt from 2012 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Edwards Lifesciences long term debt for the quarter ending September 30, 2025 was $0.598B, a 0.12% increase year-over-year.
- Edwards Lifesciences long term debt for 2024 was $0.598B, a 0.12% increase from 2023.
- Edwards Lifesciences long term debt for 2023 was $0.597B, a 0.12% increase from 2022.
- Edwards Lifesciences long term debt for 2022 was $0.596B, a 0.1% increase from 2021.
|
Edwards Lifesciences Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $598 |
| 2023 | $597 |
| 2022 | $596 |
| 2021 | $596 |
| 2020 | $595 |
| 2019 | $594 |
| 2018 | $594 |
| 2017 | $438 |
| 2016 | $822 |
| 2015 | $597 |
| 2014 | $598 |
| 2013 | $593 |
| 2012 | $189 |
| 2011 | $150 |
|
Edwards Lifesciences Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | $598 |
| 2025-06-30 | $598 |
| 2025-03-31 | $598 |
| 2024-12-31 | $598 |
| 2024-09-30 | $598 |
| 2024-06-30 | $597 |
| 2024-03-31 | $597 |
| 2023-12-31 | $597 |
| 2023-09-30 | $597 |
| 2023-06-30 | $597 |
| 2023-03-31 | $597 |
| 2022-12-31 | $596 |
| 2022-09-30 | $596 |
| 2022-06-30 | $596 |
| 2022-03-31 | $596 |
| 2021-12-31 | $596 |
| 2021-09-30 | $596 |
| 2021-06-30 | $595 |
| 2021-03-31 | $595 |
| 2020-12-31 | $595 |
| 2020-09-30 | $595 |
| 2020-06-30 | $595 |
| 2020-03-31 | $595 |
| 2019-12-31 | $594 |
| 2019-09-30 | $594 |
| 2019-06-30 | $594 |
| 2019-03-31 | $594 |
| 2018-12-31 | $594 |
| 2018-09-30 | $594 |
| 2018-06-30 | $594 |
| 2018-03-31 | $456 |
| 2017-12-31 | $438 |
| 2017-09-30 | $1,034 |
| 2017-06-30 | $1,017 |
| 2017-03-31 | $848 |
| 2016-12-31 | $822 |
| 2016-09-30 | $601 |
| 2016-06-30 | $603 |
| 2016-03-31 | $602 |
| 2015-12-31 | $597 |
| 2015-09-30 | $605 |
| 2015-06-30 | $600 |
| 2015-03-31 | $603 |
| 2014-12-31 | $598 |
| 2014-09-30 | $596 |
| 2014-06-30 | $598 |
| 2014-03-31 | $725 |
| 2013-12-31 | $593 |
| 2013-09-30 | $532 |
| 2013-06-30 | $227 |
| 2013-03-31 | $193 |
| 2012-12-31 | $189 |
| 2012-09-30 | $175 |
| 2012-06-30 | $185 |
| 2012-03-31 | $179 |
| 2011-12-31 | $150 |
| 2011-09-30 | $175 |
| 2011-06-30 | $175 |
| 2011-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $49.407B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $239.063B | 28.41 |
| Intuitive Surgical (ISRG) | United States | $187.731B | 73.45 |
| IDEXX Laboratories (IDXX) | United States | $55.613B | 55.23 |
| IQVIA Holdings (IQV) | United States | $41.110B | 22.92 |
| Alcon (ALC) | Switzerland | $40.371B | 27.21 |
| Mettler-Toledo (MTD) | United States | $29.477B | 34.49 |
| DexCom (DXCM) | United States | $28.124B | 38.77 |
| STERIS (STE) | Ireland | $25.634B | 26.46 |
| Waters (WAT) | United States | $23.623B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.267B | 32.88 |
| Hologic (HOLX) | United States | $16.749B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.665B | 0.00 |
| Penumbra (PEN) | United States | $14.008B | 98.53 |
| Globus Medical (GMED) | United States | $12.601B | 26.45 |
| Masimo (MASI) | United States | $7.854B | 25.17 |
| Glaukos (GKOS) | United States | $7.131B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.163B | 19.58 |
| TransMedics (TMDX) | United States | $4.573B | 54.17 |
| Teleflex (TFX) | United States | $4.550B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.455B | 18.66 |
| Veracyte (VCYT) | United States | $3.423B | 39.01 |
| Integer Holdings (ITGR) | United States | $3.048B | 14.31 |
| Alphatec Holdings (ATEC) | United States | $2.530B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.422B | 22.66 |
| Artivion (AORT) | United States | $2.099B | 96.33 |
| UFP Technologies (UFPT) | United States | $2.045B | 27.00 |
| Nihon Kohden (NHNKY) | Japan | $1.953B | 17.05 |
| PROCEPT BioRobotics (PRCT) | United States | $1.729B | 0.00 |
| AxoGen (AXGN) | United States | $1.523B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.406B | 0.00 |
| IRadimed (IRMD) | United States | $1.313B | 62.56 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.973B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| SiBone (SIBN) | United States | $0.737B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.731B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.725B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.681B | 39.62 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.597B | 11.91 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.550B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.467B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.436B | 0.00 |
| RxSight (RXST) | United States | $0.409B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| Sight Sciences (SGHT) | United States | $0.337B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.204B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.156B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Solana (HSDT) | United States | $0.125B | 0.00 |
| Hyperfine (HYPR) | United States | $0.124B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.42 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |